# Can You Switch From Tirzepatide to Semaglutide? | Buy This GLP

What a case report, a UK service review and a randomized head-to-head trial tell us about switching from tirzepatide to semaglutide.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/can-you-switch-from-tirzepatide-to-semaglutide
Updated: 2026-11-15
Published: 2026-09-17

[← Research](https://buythisglp.com/research)

Evidence

# Can You Switch From Tirzepatide to Semaglutide?

A published case and a UK service report describe the switch. Neither establishes how much weight people typically lose after changing treatments.

Editorial profile: [Wesley Jenkins](https://buythisglp.com/authors/wesley-jenkins)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20264 min readUpdated November 2026

Weight at each visit in one published case · Starting weight: 115 kg · First 6 months · Tirzepatide · 109.5 kg · Next 6 months · Semaglutide · 92 kg · 20% below the starting weight after 12 months.

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

A prescriber can consider switching from tirzepatide to semaglutide when semaglutide is appropriate for the condition being treated. The U.S. Wegovy and Zepbound labels advise against combining them with other GLP-1 medicines. Ask your prescriber to plan the change [\[4\]](https://buythisglp.com/research/can-you-switch-from-tirzepatide-to-semaglutide#ref-4) [\[5\]](https://buythisglp.com/research/can-you-switch-from-tirzepatide-to-semaglutide#ref-5).

## Key takeaways

-   One published patient lost more weight after switching to semaglutide. A single case cannot tell us how often that happens.
-   A UK conference report described switching in routine care, with short-term side-effect monitoring. It did not estimate long-term weight loss.
-   The SURMOUNT-5 head-to-head trial compared starting the two drugs and did not test this switch.

## What direct evidence on the switch shows

The evidence on [switching from semaglutide to tirzepatide](https://buythisglp.com/research/can-you-switch-from-semaglutide-to-tirzepatide) includes different patients and study designs. In one report on the reverse switch, a 40-year-old man with obesity lost less than 5% of his weight during six months of tirzepatide treatment. His weight went from 115 kg at baseline to 109.5 kg before switching and 92 kg six months after starting semaglutide. The 20% figure measures total loss from his original baseline [\[1\]](https://buythisglp.com/research/can-you-switch-from-tirzepatide-to-semaglutide#ref-1).

A UK service reported at the 2026 UK Congress on Obesity that it switched 3,291 patients from tirzepatide to semaglutide. It reviewed reports of potentially significant side effects over a short period. The abstract did not report weight outcomes after switching or estimate a comparative safety effect [\[2\]](https://buythisglp.com/research/can-you-switch-from-tirzepatide-to-semaglutide#ref-2).

What one case can tell us

The patient took the drugs in sequence. The case cannot separate the effect of changing medicine from other changes over time, or predict what will happen for another person [\[1\]](https://buythisglp.com/research/can-you-switch-from-tirzepatide-to-semaglutide#ref-1).

## What the head-to-head trial measured

In SURMOUNT-5, adults with obesity and without type 2 diabetes were assigned to tirzepatide or semaglutide. Estimated average weight loss at week 72 was 20.2% with tirzepatide compared with 13.7% with semaglutide. Those figures come from separate randomized groups. The trial did not measure weight after changing from tirzepatide to semaglutide[\[3\]](https://buythisglp.com/research/can-you-switch-from-tirzepatide-to-semaglutide#ref-3).

## What to discuss with your prescriber

The [monthly GLP-1 cost guide](https://buythisglp.com/research/how-much-does-a-glp1-cost-per-month) explains how cash prices, coverage and drug formulation affect the bill. Bring information about why you want to switch and how you responded to your current medicine so the prescriber can weigh treatment options.

## Frequently asked

Can you switch from tirzepatide to semaglutide?

A prescriber can consider the change if semaglutide is appropriate for you. The Wegovy and Zepbound prescribing information advises against combining these medicines with other GLP-1 therapy.

Can you predict weight loss after switching?

The published case describes one patient's response, and the UK conference report did not give long-term weight outcomes. The randomized head-to-head trial compared separate groups and did not study a switch.

## Sources

1.  \[1\] La Vignera S, Condorelli RA (2026). Tirzepatide non-response with subsequent semaglutide response in class 2 obesity JCEM Case Reports. [PMID 42670558](https://doi.org/10.1210/jcemcr/luag245)
2.  \[2\] Kenneally S (2026). Dosing protocol for switching patients with overweight/obesity between semaglutide and tirzepatide based on prescribing data International Journal of Obesity, UK Congress on Obesity abstract P20. [Source](https://www.nature.com/articles/s41366-026-02216-x)
3.  \[3\] Aronne LJ, Horn DB, le Roux CW, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity New England Journal of Medicine. [PMID 40353578](https://www.nejm.org/doi/10.1056/NEJMoa2416394)
4.  \[4\] Novo Nordisk (2026). Wegovy prescribing information DailyMed, U.S. National Library of Medicine. [Source](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
5.  \[5\] Eli Lilly and Company (2026). Zepbound prescribing information DailyMed, U.S. National Library of Medicine. [Source](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)

## Where to get it

### Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

[Open the price desk →](https://buythisglp.com/)

## More in Evidence

-   [
    
    50,678 adults with a BMI of 30 or more · Prescribed · 8.0% · Filled · 4.4% · Outlined bar runs to 10%. Medicaid had lower odds of both.
    
    ### Does Medicaid Cover Weight Loss Drugs? It Depends on Your State
    
    ](https://buythisglp.com/research/does-medicaid-cover-weight-loss-drugs)
-   [
    
    What the claim rests on · Sleep study · AHI 15 or more · Obesity · BMI 30 or more · Prescription · for sleep apnea · Part D claim · plan review · Trial thresholds shown. Your plan sets its approval requirements.
    
    ### Does Medicare Cover Zepbound for Sleep Apnea? The Diagnosis Is the Key
    
    ](https://buythisglp.com/research/does-medicare-cover-zepbound-for-sleep-apnea)
-   [
    
    Illustrative decline with a one-week half-life · Ozempic window: up to 5 days late · 100% · day 0 · 82% · day 2 · 67% · day 4 · 61% · day 5 · 50% · day 7 · A calculation from the label half-life, not a blood test.
    
    ### What Happens If You Miss a Dose of Ozempic? A Week-Long Half-Life Buys Time
    
    ](https://buythisglp.com/research/what-happens-if-you-miss-a-dose-of-ozempic)
